Chest
DIAGNOSIS AND MANAGEMENT OF LUNG CANCER: ACCP GUIDELINES (2ND EDITION)Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Section snippets
Materials and Methods
To update previous recommendations on the initial evaluation of the patient with lung cancer, guidelines on lung cancer diagnosis and management published between 2002 and May 2005 were identified by a systematic review of the literature (see “Methodology for Lung Cancer Evidence Review and Guidelines Development” section). Those guidelines including recommendations that are specific to the initial evaluation of the lung cancer patient were identified for possible inclusion in this section.
Presenting Symptoms of Lung Cancer
Initial presenting symptoms in patients with lung cancer may be respiratory related, but are often constitutional and attributable to metastatic disease (Table 1).2, 3, 4, 5, 6, 7 Cough is reported to be the most common presenting symptom of lung cancer; other respiratory symptoms include dyspnea, chest pain, and hemoptysis.8, 9, 10 Patients with lung cancer usually present with multiple symptoms, including both respiratory and constitutional.8, 9 In a series of 678 consecutive lung cancer
Recommendation
- 1
It is recommended that patients with known or suspected lung cancer receive timely and efficient care. Grade of recommendation, 1C
Presenting Radiographic Features of Lung Cancer
The chest radiograph plays a pivotal role in the recognition of lung cancer. Certainly, in the asymptomatic patient an abnormality on the chest radiograph would be the first clue to the presence of lung cancer. In patients with symptoms related to the primary tumor, the chest radiograph may often strongly support a suspicion of carcinoma of the lung. For patients presenting with either nonspecific systemic complaints or symptoms suggestive of metastatic disease, the chest radiograph will be
Symptoms Related to the Primary Tumor
Of the presenting symptoms in patients with lung cancer, cough, dyspnea, chest pain, and hemoptysis may be related to the primary tumor (Table 1). Cough is the most common presenting symptom in patients with lung cancer. Many lung cancers occur in the central airways and may lead to postobstructive pneumonia or may cause lymph node enlargement, which may lead to cough. The failure of acute exacerbations of COPD to clear should raise suspicion of the presence of a neoplasm. Dyspnea develops
Symptoms and Signs of Intrathoracic Spread
The intrathoracic spread of lung cancer, either by direct extension or lymphatic spread, produces a variety of symptoms and signs. These may be caused by the involvement of nerves (eg, recurrent laryngeal nerve, phrenic nerve, brachial plexus, and sympathetic nerve trunks), chest wall and pleura, vascular structures (eg, superior vena cava, pericardium, and heart), and visceral structures (eg, the esophagus).
Recurrent laryngeal nerve palsy, which causes hoarseness, has been reported in 2 to 18%
Symptoms, Signs, and Laboratory Tests Indicating Extrathoracic Metastases
About one third of patients present with symptoms as a result of distant metastases. The most common sites of distant metastasis from lung cancer are the bones; liver; adrenal glands and intraabdominal lymph nodes; brain and spinal cord; and lymph nodes and skin. Lung cancer can metastasize to virtually any bone, although the axial skeleton and proximal long bones are most commonly involved. The primary symptom resulting from bone involvement is pain, which may have a pleuritic component when
Standardized Evaluation for Systemic Metastases
Carbone et al11 and Feinstein and colleagues38, 39, 40, 41, 42 have explored the relationship between symptoms at presentation and prognosis in a large cohort of consecutive lung cancer patients. Patients with the best prognosis were either asymptomatic or had symptoms referable only to the primary tumor. In patients either with systemic symptoms of anorexia, weight loss, and fatigue or with symptoms attributable to metastatic disease, prognosis was especially poor. The relationship between
Recommendation
- 2
It is recommended that all patients with known or suspected lung cancer give a thorough history and undergo a thorough physical examination and standard laboratory tests as a screen for metastatic disease. Grade of recommendation, 1B
Paraneoplastic Syndromes
Paraneoplastic syndromes are a group of clinical disorders that are associated with malignant diseases that are not directly related to the physical effects of primary or metastatic tumors.48, 49 Paraneoplastic syndromes may occur in 10% of patients with bronchogenic carcinoma.2, 3 The extent of paraneoplastic symptoms is unrelated to the size of the primary tumor, and in some cases can precede the diagnosis of malignant disease. At other times they may occur late in the illness, or herald the
Hypercalcemia
The incidence of hypercalcemia in patients with lung cancer ranges from 2 to 6% at presentation to 8 to 12% throughout the course of the disease. Symptoms include nausea, vomiting, abdominal pain, constipation, polyuria, thirst, dehydration, confusion, and irritability. Squamous cell carcinoma is most frequently associated with hypercalcemia. Although bone metastases may be found in patients with lung cancer and hypercalcemia, most commonly humoral mechanisms account for the hypercalcemia.50, 51
Digital Clubbing and Hypertrophic Osteoarthropathy
Digital clubbing is an enlargement of the terminal segments of the fingers and/or toes due to proliferation of connective tissue beneath the nail matrix. Quantitative indexes of the nail profile angle, hyponychial angle and phalangeal depth ratio can be determined to assist in identifying clubbing.69 Hypertrophic osteoarthropathy (HOA) is a systemic disorder, which involves both a painful symmetrical arthropathy, usually of the ankles, wrists, and knees, and periosteal new bone formation in the
Neurologic Syndromes
A variety of poorly understood neurologic syndromes may occur in patients with lung cancer.46 The diagnosis of a neurologic paraneoplastic syndrome is made once other causes, such as electrolyte imbalance, metastatic disease, cerebral and spinal vascular disease, infections, and treatment toxicity, are excluded. The neurologic syndromes include the Lambert-Eaton myasthenic syndrome (LEMS), limbic encephalopathy, polyneuropathy, cerebellar degeneration, retinopathy, opsoclonus-myoclonus, and
Recommendation
- 3
It is recommended that patients with lung cancer and a paraneoplastic syndrome not be precluded from potentially curative therapy on the basis of these symptoms alone. Grade of recommendation, 2C
Summary
Most patients with lung cancer will be symptomatic at presentation. A minority of patients presents with symptoms related to the primary tumor, but most patients present with either nonspecific systemic symptoms, including anorexia, weight loss, and fatigue, or specific symptoms indicating metastatic disease. Asymptomatic patients and patients with symptoms related to the primary tumor have better 5-year survival rates than those patients with systemic symptoms or symptoms indicating metastatic
REFERENCES (89)
Clinical aspects of lung cancer
Semin Roentgenol
(1990)- et al.
Clinical manifestations of lung cancer
Chest
(1974) - et al.
Carcinoma of the lung
Ann Thorac Surg
(1980) - et al.
Diagnostic tests for lung cancer
Mayo Clin Proc
(1993) - et al.
A prospective study of a total material of lung cancer from a county in Sweden 1997–1999
Lung Cancer
(2002) - et al.
Patient's and doctors' delays in the diagnosis of chest tumors
Lung Cancer
(2002) - et al.
Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer
J Thorac Cardiovasc Surg
(2003) - et al.
Influence of delays on survival in the surgical treatment of bronchogenic carcinoma
Lung Cancer
(2002) - et al.
Carcinoma of the lung: an analysis of 362 cases diagnosed and treated in one year
Br J Dis Chest
(1962) - et al.
The changing radiographic presentation of bronchogenic carcinoma with reference to cell types
Chest
(1996)
Radiographic manifestations of primary bronchogenic carcinoma
Radiol Clin North Am
Detecting lung cancer as a cause of hemoptysis in patients with a normal chest radiograph
Chest
Prognostic value of the superior vena cava syndrome as the presenting sign of small cell anaplastic carcinoma of the lung
Eur J Cancer
Rapid diagnosis of lung cancer from palpable metastases by needle thrust
Chest
Computed tomographic scanning of the brain in the initial staging of bronchogenic carcinoma
Chest
The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma
Chest
Staging of non-small cell bronchogenic carcinoma
Chest
Paraneoplastic syndromes associated with lung cancer
Mayo Clin Proc
Ectopic secretion of neurohypophyseal peptides in patients with malignancy
Endocrinol Metab Clin North Am
Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma
Am J Med
Ectopic production of lipotropin by cancer
Am J Med
Digital clubbing and hypertrophic osteoarthropathy
Br J Dis Chest
Digital clubbing and lung cancer
Chest
Hypertrophic pulmonary osteoarthropathy
Dis Chest
Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma
Mayo Clin Proc
Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell carcinoma
Lancet
Symptoms, signs and staging of lung cancer
Eur Respir Mon
Diagnosis of symptomatic lung cancer
Semin Respir Med
American Thoracic Society European Respiratory Society.. Pretreatment evaluation of non-small-cell lung cancer
Am J Respir Crit Care Med
Lung cancer: clinical presentation and specialist referral time
Eur Respir J
Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis
Thorax
What are the clinical features of lung cancer before the diagnosis is made? A population based case-controlled study
Thorax
Lung cancer: perspectives and prospects
Ann Intern Med
Diagnosis of lung cancer in primary care: a structured review
Fam Pract
The probability of specific diagnoses for patients presenting with common symptoms to Dutch Family physicians
J Fam Pract
Effect of delays on prognosis in patients with non-small cell lung cancer
Thorax
British Thoracic Society.. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer: The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee
Thorax
Lung cancer
Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators
Bronchial carcinomas: lobar distribution of lesions in 250 cases
Calif Med
Prediliction of lung cancer for the upper lobes: an epidemiologic inquiry
J Natl Cnacer Inst
Radiographic abnormalities in carcinoma of the lung in relation to histological cell type
Thorax
The changing histopathology of lung cancer
Cancer
1976 Caldwell lecture: varying manifestation of peripheral pulmonary neoplasms
AJR Am J Roentgenol
Comparison of computerized tomography with fiberoptic bronchoscopy in identifying endobronchial abnormalities in patients with known or suspected lung cancer
Am Rev Respir Dis
Cited by (0)
The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).